CRSP vs BEAM
CRSP 与 BEAM 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | CRSPCRISPR THERAPEUTICS AG | BEAMBeam Therapeutics Inc. |
|---|---|---|
| 市值 | $4.97B | $2.81B |
| 市净率 | — | 2.64 |
| 市销率 | 1415.8x | 20.1x |
| 营收 | — | $156.03M(TTM) |
| 营收同比增长 | -90.6% | 120.0% |
| 净利润 | — | -$86.52M(TTM) |
| 净利同比增长 | -58.8% | 78.8% |
| 每股收益(稀释) | — | $-0.69(TTM) |
| 息税前利润率 | -18933.6% | -274.6% |
| 净资产收益率 | -33.3% | -7.5% |
| 投入资本回报率 | -32.6% | -40.5% |
| 一年总回报 | -15.9% | +14.4% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:CRSP vs BEAM
| 指标 | CRSP | BEAM |
|---|---|---|
| 期末价值 | $9.5K | $14.5K |
| 总回报 | -5.4% | +45.2% |
| 年化收益 (CAGR) | -0.8% | +5.7% |
| 波动率 | 61.6% | 79.6% |
| 夏普比率 | 0.22 | 0.41 |
| 索提诺比率 | 0.34 | 0.63 |
| 最大回撤 | -85.1% | -89.1% |
基于 1693 个共同交易日,2020-02-06 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)